DeutschNewstral
Article
bizjournals.com on 2018-03-27 13:37
Penn gene therapy spinout raises $9.2M
Related news
- Penn cell and gene therapy spinout Interius Biotherapeutics raises $76 millionbizjournals.com
- Penn gene therapy spinout exceeds projections with $216M IPObizjournals.com
- MIT gene-therapy spinout raises $6M, enters competitive mRNA fieldbizjournals.com
- Penn spinout raises $2Mbizjournals.com
- Penn gene therapy spinout taking on rare retinal diseases launches with $19M in seed fundingbizjournals.com
- Battelle gene therapy spinout raises $100M as it expands in New Albanybizjournals.com
- Lab Notes: AmerisourceBergen aims to help cell and gene therapy developers, Penn spinout expands research deal with universitybizjournals.com
- Penn spinout led by veteran pharma execs emerges from stealth mode, raises $50M to advance gene-editing technologybizjournals.com
- Penn spinout Tmunity Therapeutics raises another $35Mbizjournals.com
- Penn spinout developing cancer treatments raises $1Mbizjournals.com
- Bootstrapped UNC spinout lands $300K for gene therapy workbizjournals.com
- Penn spinout Verismo Therapeutics raises $16M to advance cell therapiesbizjournals.com
- Gene therapy developer Gyroscope Technologies raises $60.6Mbizjournals.com
- Bala Cynwyd gene therapy company raises $52Mbizjournals.com
- Vertex-partnered gene therapy startup raises $110Mbizjournals.com
- Cell and gene therapy startup raises $525Mbizjournals.com
- Chapel Hill gene therapy startup raises $50Mbizjournals.com
- Why this UC Berkeley gene therapy spinout is targeting a $100 million IPObizjournals.com
- In defining moment, spinout from Nobel Prize winner Jennifer Doudna's lab inks gene therapy dealbizjournals.com
- Battelle gene therapy spinout expanding to New Albany, adding 260 jobsbizjournals.com